Pfizer

PFE · NYSE · USD

$27.63−1.76%−$0.50

Close · October 2, 2026

At a glance

Revenue growth: −1.65%; 2025 vs 2024
Net income growth: −3.24%; 2025 vs 2024
Net margin: 12.4%; 2024: 12.6%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	208,160	213,396	226,501	197,205	181,476	154,229	167,594	159,422	171,797	171,615
Current assets	42,898	50,358	43,333	51,259	59,693	35,067	32,803	49,926	41,142	38,949
Cash and equivalents	1,142	1,043	2,853	416	1,944	1,786	1,121	1,139	1,342	2,595
Short-term investments	12,454	19,434	9,837	22,316	29,125	10,437	8,525	17,694	18,650	15,255
Receivables	15,841	14,777	15,544	14,529	15,745	11,177	9,508	11,399	11,271	11,266
Inventory	10,654	10,851	10,189	8,981	9,059	8,020	7,068	7,508	7,578	6,783
Net property, plant and equipment	21,530	20,682	21,864	19,276	17,721	15,131	14,258	13,385	13,865	13,318
Goodwill	71,264	68,527	67,783	51,375	49,208	49,556	48,202	53,411	55,952	54,449
Other intangible assets	53,731	55,411	64,900	43,370	25,146	28,337	33,936	35,211	48,741	52,648
Long-term investments	1,527	2,108	15,382	14,926	21,348	20,379	20,413	3,102	7,492	7,715
Current liabilities	36,984	42,995	47,794	42,138	42,671	25,920	37,304	31,858	30,427	31,115
Accounts payable	5,240	5,633	6,710	6,809	5,578	4,283	3,887	4,674	4,656	4,536
Long-term debt	61,856	57,802	61,813	33,205	36,195	37,133	35,955	33,287	33,715	31,545
Total debt	67,490	64,222	67,236	38,992	40,790	40,563	38,716	38,068	37,262	35,771
Total liabilities	121,385	124,899	137,213	101,288	104,013	90,756	104,148	95,664	100,141	111,775
Total equity (incl. minority)	86,775	88,497	89,288	95,917	77,463	63,473	63,446	63,758	71,656	59,840
Retained earnings	114,610	116,725	118,353	125,656	103,394	90,392	97,670	89,554	85,291	71,774
Minority interest	299	294	274	256	262	235	303	351	348	296